Tim Hanna, Radiation Oncologist at Kingston General Hospital, shared an article by Arjun Gupta, et al. on LinkedIn:
“In this population-based cohort study, patients receiving systemic therapy as part of trials experienced a lower percentage of contact days, accounted for by greater hospitalization rates in routine practice.
Addressing the predominantly outpatient, protocol-mandated visits may represent opportunities to decrease trial-related time toxicity.”
Health Care Contact Days and Outcomes in Clinical Trials vs Routine Care Among Patients With Non–Small Cell Lung Cancer.
Authors: Arjun Gupta, et al.
More posts featuring Tim Hanna.